These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 10371074)

  • 21. [Idiopathic intracranial hypertension and factor V Leiden mutation].
    Younes S; Aissi M; Chérif Y; Daoussi N; Boughammoura A; Frih Ayed M; Sfar MH; Jerbi S
    J Mal Vasc; 2014 Jul; 39(4):270-3. PubMed ID: 24908418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Activated protein C resistance and factor V Leiden: clinical interest].
    Guermazi S; Znazen R
    Pathol Biol (Paris); 2011 Oct; 59(5):281-5. PubMed ID: 19896782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [National evaluation of the diagnosis of activated protein C resistance].
    Montiel-Manzano G; de la Peña-Díaz A; Majluf-Cruz A; Cesarman-Maus G; Corona-de la Peña N; Cruz-Cruz D; Gaminio E; Martínez-Murillo C; Mayagoitia T; Miranda-Peralta E; Poblete T; Quintana-Martínez S; Ramírez R; Razo D; Ruiz de Chávez-Ochoa A; Reyes-Núñez VA; Salazar R; Vicencio-Santiago GV; Villa R
    Rev Invest Clin; 2003; 55(3):358-69. PubMed ID: 14515684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activated protein C resistance in young African American patients with ischemic stroke.
    Chaturvedi S; Joshi N; Dzieczkowski J
    J Neurol Sci; 1999 Mar; 163(2):137-9. PubMed ID: 10371074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance to activated protein C--frequent etiologic factor for venous thrombosis.
    Simkova M; Simko F; Kovacs L
    Bratisl Lek Listy; 2001; 102(5):240-7. PubMed ID: 11725376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factor V Leiden as a common genetic risk factor for venous thromboembolism.
    Horne MK; McCloskey DJ
    J Nurs Scholarsh; 2006; 38(1):19-25. PubMed ID: 16579319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activated protein C resistance and factor V Leiden: a review.
    Rosendorff A; Dorfman DM
    Arch Pathol Lab Med; 2007 Jun; 131(6):866-71. PubMed ID: 17550313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.
    Marchiori A; Mosena L; Prins MH; Prandoni P
    Haematologica; 2007 Aug; 92(8):1107-14. PubMed ID: 17650440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obstetric implications of activated protein C resistance and factor V Leiden mutation.
    Gherman RB; Goodwin TM
    Obstet Gynecol Surv; 2000 Feb; 55(2):117-22. PubMed ID: 10674255
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.